Mark A. Atkinson

60.1k total citations · 11 hit papers
637 papers, 40.2k citations indexed

About

Mark A. Atkinson is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mark A. Atkinson has authored 637 papers receiving a total of 40.2k indexed citations (citations by other indexed papers that have themselves been cited), including 386 papers in Genetics, 341 papers in Surgery and 241 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mark A. Atkinson's work include Diabetes and associated disorders (353 papers), Pancreatic function and diabetes (289 papers) and Diabetes Management and Research (229 papers). Mark A. Atkinson is often cited by papers focused on Diabetes and associated disorders (353 papers), Pancreatic function and diabetes (289 papers) and Diabetes Management and Research (229 papers). Mark A. Atkinson collaborates with scholars based in United States, United Kingdom and Germany. Mark A. Atkinson's co-authors include George S. Eisenbarth, Clive Wasserfall, Noel K. Maclaren, Desmond Schatz, Aaron W. Michels, Todd M. Brusko, Martha Campbell‐Thompson, Michael Clare‐Salzler, Edward H. Leiter and Franklin H. Epstein and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Mark A. Atkinson

622 papers receiving 39.0k citations

Hit Papers

Type 1 diabetes 1993 2026 2004 2015 2013 2001 1993 1994 2015 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Type 1 diabetes
    2013 1.8k citations Mark A. Atkinson, Aaron W. Michels et al. profile →
  2. Type 1 diabetes: new perspectives on disease pathogenesis and treatment
    2001 1.1k citations Mark A. Atkinson et al. profile →
  3. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes
    1993 890 citations Mark A. Atkinson et al. profile →
  4. The Pathogenesis of Insulin-Dependent Diabetes Mellitus
    1994 800 citations Mark A. Atkinson et al. profile →
  5. Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
    2015 735 citations Mark A. Atkinson, Peter A. Gottlieb et al. profile →
  6. Toward defining the autoimmune microbiome for type 1 diabetes
    2010 618 citations Adriana Giongo, George Casella et al. The ISME Journal profile →
  7. Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
    2011 617 citations Adriana Giongo, George Casella et al. profile →
  8. Phosphorylation of the MAP Kinase ERK2 Promotes Its Homodimerization and Nuclear Translocation
    1998 576 citations Mark A. Atkinson et al. profile →
  9. Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes
    1998 550 citations Desmond Schatz, Mark A. Atkinson et al. profile →
  10. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients
    2012 509 citations Ken Coppieters, Francesco Dotta et al. The Journal of Experimental Medicine profile →
  11. Targeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes
    2019 248 citations Mark A. Atkinson et al. Cell Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Atkinson United States 101 19.5k 17.6k 12.5k 9.0k 9.0k 637 40.2k
Stephen S. Rich United States 85 12.3k 0.6× 5.4k 0.3× 5.3k 0.4× 7.3k 0.8× 4.5k 0.5× 634 32.1k
Chantal Mathieu Belgium 105 8.8k 0.5× 11.0k 0.6× 17.2k 1.4× 9.8k 1.1× 6.2k 0.7× 870 47.3k
Jerome I. Rotter United States 80 8.3k 0.4× 5.5k 0.3× 3.5k 0.3× 6.1k 0.7× 3.4k 0.4× 494 22.0k
Yehuda Shoenfeld Israel 115 6.2k 0.3× 6.6k 0.4× 3.0k 0.2× 8.2k 0.9× 20.2k 2.3× 1.6k 63.1k
Charis Eng United States 106 7.6k 0.4× 7.8k 0.4× 8.4k 0.7× 24.0k 2.6× 2.4k 0.3× 647 44.8k
Tim D. Spector United Kingdom 119 6.9k 0.4× 7.2k 0.4× 2.7k 0.2× 16.7k 1.8× 2.2k 0.2× 722 52.2k
Mark I. McCarthy United Kingdom 95 13.3k 0.7× 5.9k 0.3× 5.3k 0.4× 13.0k 1.4× 1.5k 0.2× 516 36.4k
John Danesh United Kingdom 59 4.6k 0.2× 5.8k 0.3× 4.0k 0.3× 3.9k 0.4× 2.8k 0.3× 129 29.9k
Cisca Wijmenga Netherlands 92 7.4k 0.4× 4.1k 0.2× 974 0.1× 15.3k 1.7× 5.9k 0.7× 408 32.1k
David W. Russell United States 126 11.2k 0.6× 12.4k 0.7× 7.1k 0.6× 29.5k 3.3× 3.6k 0.4× 542 52.6k

Countries citing papers authored by Mark A. Atkinson

Since Specialization
Citations

This map shows the geographic impact of Mark A. Atkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Atkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Atkinson more than expected).

Fields of papers citing papers by Mark A. Atkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Atkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Atkinson. The network helps show where Mark A. Atkinson may publish in the future.

Co-authorship network of co-authors of Mark A. Atkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Atkinson. A scholar is included among the top collaborators of Mark A. Atkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Atkinson. Mark A. Atkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Butterworth, Elizabeth A., Nataliya Lenchik, Jing Chen, et al.. (2025). Beta cell dysfunction occurs independently of insulitis in type 1 diabetes pathogenesis. Cell Reports. 44(9). 116174–116174. 1 indexed citations
2.
Atkinson, Mark A. & Raghavendra G. Mirmira. (2023). The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas. Cell Metabolism. 35(9). 1500–1518. 59 indexed citations
3.
Girdhar, Kiran, Qian Huang, I‐Ting Chow, et al.. (2022). A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes. Proceedings of the National Academy of Sciences. 119(31). e2120028119–e2120028119. 63 indexed citations
4.
Abdullah, Mohamed Ahmed, Janelle A. Noble, Mohammed Hussien, et al.. (2021). Clinical features, biochemistry, and HLA‐DRB1 status in youth‐onset type 1 diabetes in Sudan. Pediatric Diabetes. 22(5). 749–757. 12 indexed citations
5.
Jacobsen, Laura M., Brian N. Bundy, Desmond Schatz, et al.. (2020). Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 Diabetes. Diabetes Technology & Therapeutics. 22(12). 948–953. 39 indexed citations
6.
Cook, Dana P., João Paulo Monteiro Carvalho Móri da Cunha, Pieter-Jan Martens, et al.. (2020). Intestinal Delivery of Proinsulin and IL-10 via Lactococcus lactis Combined With Low-Dose Anti-CD3 Restores Tolerance Outside the Window of Acute Type 1 Diabetes Diagnosis. Frontiers in Immunology. 11. 1103–1103. 23 indexed citations
7.
Edwards, David, Alexander van der Jagt, Tuija Sievänen, et al.. (2019). DIABOLO Task 3.2.2. Development and harmonization of social indicators. OSF Preprints (OSF Preprints). 1 indexed citations
8.
Kaestner, Klaus H., Alvin C. Powers, Ali Naji, & Mark A. Atkinson. (2019). NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP). Diabetes. 68(7). 1394–1402. 96 indexed citations
9.
Ostrov, David A., Aimon K. Alkanani, Kristen A. McDaniel, et al.. (2018). Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes. Journal of Clinical Investigation. 128(5). 1888–1902. 40 indexed citations
10.
Coppieters, Ken, Francesco Dotta, Natalie Amirian, et al.. (2012). Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. The Journal of Experimental Medicine. 209(1). 51–60. 509 indexed citations breakdown →
11.
Zhang, Qibin, Thomas Fillmore, Athena Schepmoes, et al.. (2012). Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes. The Journal of Experimental Medicine. 210(1). 191–203. 78 indexed citations
12.
Atkinson, Mark A. & Alexander V. Chervonsky. (2012). Does the gut microbiota have a role in type 1 diabetes? Early evidence from humans and animal models of the disease. Diabetologia. 55(11). 2868–2877. 70 indexed citations
13.
Shoda, Lisl K.M., Huub T. C. Kreuwel, Kapil Gadkar, et al.. (2010). The Type 1 Diabetes PhysioLab® Platform: a validated physiologically based mathematical model of pathogenesis in the non-obese diabetic mouse. Clinical & Experimental Immunology. 161(2). 250–267. 43 indexed citations
14.
Roesch, Luiz Fernando Würdig, Graciela L. Lorca, George Casella, et al.. (2009). Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat model. The ISME Journal. 3(5). 536–548. 192 indexed citations
15.
Wasserfall, Clive, Matthew Parker, Kieran McGrail, et al.. (2009). Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area. Journal of Diabetes and its Complications. 24(3). 163–167. 17 indexed citations
16.
Zhang, Chunyan, Иван Тодоров, Chia-Lei Lin, et al.. (2007). Elimination of insulitis and augmentation of islet β cell regeneration via induction of chimerism in overtly diabetic NOD mice. Proceedings of the National Academy of Sciences. 104(7). 2337–2342. 40 indexed citations
17.
Serreze, David, Clive Wasserfall, Eric Ottendorfer, et al.. (2004). Diabetes Acceleration or Prevention by a Coxsackievirus B4 Infection: Critical Requirements for both Interleukin-4 and Gamma Interferon. Journal of Virology. 79(2). 1045–1052. 56 indexed citations
18.
19.
Brod, Staley A., Mark A. Atkinson, Victor Lavis, et al.. (2001). Ingested IFN- α Preserves Residual β Cell Function in Type 1 Diabetes. Journal of Interferon & Cytokine Research. 21(12). 1021–1030. 20 indexed citations
20.
Hosking, D. J., Frank G. Moody, I M Stewart, & Mark A. Atkinson. (1975). Vagal impairment of gastric secretion in diabetic autonomic neuropathy.. BMJ. 2(5971). 588–590. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen S. Rich Breakdown of academic impact, for papers by Chantal Mathieu Breakdown of academic impact, for papers by Jerome I. Rotter Breakdown of academic impact, for papers by Yehuda Shoenfeld Breakdown of academic impact, for papers by Charis Eng Breakdown of academic impact, for papers by Tim D. Spector Breakdown of academic impact, for papers by Mark I. McCarthy Breakdown of academic impact, for papers by John Danesh Breakdown of academic impact, for papers by Cisca Wijmenga Breakdown of academic impact, for papers by David W. Russell
Rankless by CCL
2026